» Articles » PMID: 37581715

Topically Applied Fullerenols Protect Against Radiation Dermatitis by Scavenging Reactive Oxygen Species

Overview
Journal Discov Nano
Date 2023 Aug 15
PMID 37581715
Authors
Affiliations
Soon will be listed here.
Abstract

Adverse skin reactions caused by ionizing radiation are collectively called radiation dermatitis (RD), and the use of nanomedicine is an attractive approach to this condition. Therefore, we designed and large-scale synthesized fullerenols that showed free radical scavenging ability in vitro. Next, we pretreated X-ray-exposed cells with fullerenols. The results showed that pretreatment with fullerenols significantly scavenged intracellular reactive oxygen species (ROS) produced and enhanced the antioxidant capacity, protecting skin cells from X-ray-induced DNA damage and apoptosis. Moreover, we induced RD in mice by applying 30 Gy of X-ray irradiation, followed by treatment with fullerenols. We found that after treatment, the RD scores dropped, and the histological results systematically demonstrated that topically applied fullerenols could reduce radiation-induced skin epidermal thickening, collagen deposition and skin appendage damage and promote hair regeneration after 35 days. Compared with Trolamine cream, a typical RD drug, fullerenols showed superior radiation protection. Overall, the in vitro and in vivo experiments proved that fullerenols agents against RD.

Citing Articles

Fullerenol C(OH): Antioxidant, Cytoprotective, Anti-Influenza Virus Activity, and Self-Assembly in Aqueous Solutions and Cell Culture Media.

Borisenkova A, Eropkin M, Konovalova N, Titova A, Markova M, Lyutova Z Antioxidants (Basel). 2025; 13(12.

PMID: 39765853 PMC: 11727559. DOI: 10.3390/antiox13121525.

References
1.
Hymes S, Strom E, Fife C . Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol. 2005; 54(1):28-46. DOI: 10.1016/j.jaad.2005.08.054. View

2.
Sharp L, Johansson H, Landin Y, Moegelin I, Bergenmar M . Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - a pilot study. Eur J Cancer. 2011; 47(18):2665-72. DOI: 10.1016/j.ejca.2011.06.039. View

3.
Jacevic V, Djordjevic A, Srdjenovic B, Milic-Tores V, Segrt Z, Dragojevic-Simic V . Fullerenol nanoparticles prevents doxorubicin-induced acute hepatotoxicity in rats. Exp Mol Pathol. 2017; 102(2):360-369. DOI: 10.1016/j.yexmp.2017.03.005. View

4.
Moding E, Kastan M, Kirsch D . Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov. 2013; 12(7):526-42. PMC: 3906736. DOI: 10.1038/nrd4003. View

5.
Zhou Y, Li J, Ma H, Zhen M, Guo J, Wang L . Biocompatible [60]/[70] Fullerenols: Potent Defense against Oxidative Injury Induced by Reduplicative Chemotherapy. ACS Appl Mater Interfaces. 2017; 9(41):35539-35547. DOI: 10.1021/acsami.7b08348. View